China COPD Drugs Market Growth of 15.56% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: AstraZeneca, GSK , Novartis - Research and Markets
China's Food and Drug Administration Approves GlaxoSmithKline's Cervarix
RedstoneConnect Wins Extension to Mobile App Pact from GlaxoSmithKline
Global Influenza Vaccine Market Outlook 2022 - Research and Markets
This ETF holds a swath of large- and mid-cap U.S. healthcare companies.
GlaxoSmithKline GSK reported solid second-quarter results on Wednesday that were largely in line with our expectations, and we don't anticipate any changes to our fair value estimate. Sales increased 10% from the prior year driven by strong sales of asthma medicine Advair, diabetes medicine ...
Five frequently asked questions for shell-shocked fund investors.
Merck's reinvigorated pipeline and Sanofi's minimal patent-loss exposure placed them atop our rankings this year, while GlaxoSmithKline joined Pfizer toward the bottom.
Worry less about beating the benchmark and more about dividend growth and achieving your desired outcomes, says Morningstar's Josh Peters.
The U.K. will remain a good hunting ground for dividend-paying stocks even if Scotland decides to become independent, says Morningstar's Josh Peters.